2006
DOI: 10.1111/j.1439-0272.2006.00723.x
|View full text |Cite
|
Sign up to set email alerts
|

The Estonian version of the National Institutes of Health chronic prostatitis symptom index

Abstract: Our aim was to establish the Estonian version of the National Institutes of Health chronic prostatitis symptom index (NIH-CPSI), and to examine its validity and applicability in chronic prostatitis patients as well as in community-based study. The questionnaire was tested in 54 category III prostatitis patients. In addition, 452 men were enrolled into a community-based study that resulted in 83 completed questionnaires. The discriminatory power, psychometric properties and internal correlations of the question… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(16 citation statements)
references
References 15 publications
0
16
0
Order By: Relevance
“…In the initial phase of study, all participants completed the questionnaires, including the Estonian version of national Institutes of Health Chronic Prostatitis Symptom Index (nIH-CPSI) (18) and International Prostate Symptom Score (I--PSS) (9) for lower urinary tract symptoms.…”
Section: Questionnairesmentioning
confidence: 99%
See 1 more Smart Citation
“…In the initial phase of study, all participants completed the questionnaires, including the Estonian version of national Institutes of Health Chronic Prostatitis Symptom Index (nIH-CPSI) (18) and International Prostate Symptom Score (I--PSS) (9) for lower urinary tract symptoms.…”
Section: Questionnairesmentioning
confidence: 99%
“…According to lower urinary tract symptoms, the subjects were divided into four groups -without LUTS score (IPSS 0) and with mild (I--PSS score 1-7), moderate (I-PSS score [8][9][10][11][12][13][14][15][16][17][18][19], and severe (I-PSS score 20-35) symptom scores (9). The separation of subjects according to total prostate volume was made using the cut-off levels of previous large-scale, long-term medical studies (14,15) and the risk for BPH progression (TPV < 30 and ≥ 30 mL, respectively) (16).…”
Section: Separation Of Subjects According To Luts and Total Prostate mentioning
confidence: 99%
“…It is desirable to incorporate a validated survey instrument such as the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) [3]. To facilitate evaluation of varied populations, the NIH-CPSI has been translated and validated for use in English [3], Spanish [4], Japanese [5], Chinese [6], Malay [6], German [7], Korean [8], Finnish [9], Italian [10], French [11], and Estonian [12]. However, a population-based study found low agreement between physician-diagnosed prostatitis and the NIH-CPSI pain measures, suggesting that the index, by itself, may have limited ability to determine the presence or absence of prostatitis [13].…”
Section: Inclusion Criteria For Epidemiological Studiesmentioning
confidence: 99%
“…The Original-American, Chinese-Malaysian, Japanese (a), Japanese (b) and Malaysian adaptations enrolled patients with CP/CPPS, patients with benign prostatic hyperplasia (BPH) patients, and healthy controls [ 9 , 13 , 31 , 32 ]. The Arabic-Egyptian, Chinese-Mainland, Estonian, Finnish, French-Canadian, Italian, Persian, and Turkish adaptations enrolled patients with CP/CPPS, and healthy controls, but patients with BPH [ 22 , 23 , 25 – 27 , 30 , 33 , 35 ]. The Original-American, Danish, German (1,2), Portuguese-Brazilian, and Spanish adaptations included only patients with CP/CPPS [ 7 , 11 , 14 , 24 , 28 , 29 , 34 ].…”
Section: Resultsmentioning
confidence: 99%